Business Description
NovelStem International Corp
NAICS : 621511
SIC : 8071
ISIN : US4362331005
Description
NovelStem International Corp focuses on the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.93 | |||||
Debt-to-Equity | -1.75 | |||||
Debt-to-EBITDA | -1.04 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -177.47 | |||||
Beneish M-Score | -10.59 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 30.4 | |||||
3-Year FCF Growth Rate | 65.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.98 | |||||
9-Day RSI | 55.1 | |||||
14-Day RSI | 62.02 | |||||
6-1 Month Momentum % | -4.45 | |||||
12-1 Month Momentum % | -73.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Days Sales Outstanding | 73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.5 | |||||
Shareholder Yield % | -91.87 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -20006.67 | |||||
Net Margin % | -28140 | |||||
FCF Margin % | -2620 | |||||
ROA % | -192.2 | |||||
ROIC % | -87.38 | |||||
ROCE % | -498.55 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 1.58 | |||||
EV-to-EBIT | -1.93 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-Revenue | 485.13 | |||||
EV-to-FCF | -18.52 | |||||
Earnings Yield (Greenblatt) % | -51.81 | |||||
FCF Yield % | -11.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NSTM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NovelStem International Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.015 | ||
EPS (TTM) ($) | -0.09 | ||
Beta | 0.16 | ||
Volatility % | 71.47 | ||
14-Day RSI | 62.02 | ||
14-Day ATR ($) | 0.001003 | ||
20-Day SMA ($) | 0.071124 | ||
12-1 Month Momentum % | -73.28 | ||
52-Week Range ($) | 0.06 - 0.2495 | ||
Shares Outstanding (Mil) | 46.88 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NovelStem International Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NovelStem International Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
NovelStem International Corp Frequently Asked Questions
What is NovelStem International Corp(NSTM)'s stock price today?
The current price of NSTM is $0.07. The 52 week high of NSTM is $0.25 and 52 week low is $0.06.
When is next earnings date of NovelStem International Corp(NSTM)?
The next earnings date of NovelStem International Corp(NSTM) is .
Does NovelStem International Corp(NSTM) pay dividends? If so, how much?
NovelStem International Corp(NSTM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |